论文部分内容阅读
COX-2与肿瘤关系密切,有希望成为现代肿瘤治疗的一个分子靶标。在临床前期研究中显示,选择性COX-2抑制剂具有增强体内肿瘤的放射反应及离体肿瘤细胞的放射敏感性的作用,就COX-2抑制剂与肿瘤放射增敏的关系的研究进展进行综述。
COX-2 is closely related to cancer and hopefully becomes a molecular target of modern cancer treatment. In preclinical studies, selective COX-2 inhibitors have been shown to enhance the radioresistance of tumor in vivo and the radiosensitivity of tumor cells in vitro. The progress of research on the relationship between COX-2 inhibitors and tumor radiosensitization Summary.